ClinVar Miner

Submissions for variant NM_006912.6(RIT1):c.270G>T (p.Met90Ile) (rs483352822)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Miraca Genetics Laboratories, RCV000722172 SCV000854625 pathogenic Noonan syndrome 8 2018-11-18 no assertion criteria provided clinical testing
GeneDx RCV000255338 SCV000322095 pathogenic not provided 2017-03-27 criteria provided, single submitter clinical testing The M90I variant in the RIT1 gene has been reported previously in a Noonan syndrome cohort as a de novo change in an individual with hypertrophic cardiomyopathy, pulmonic stenosis, atrial septal defect, ventricular septal defect and patent ductus arteriosus (Aoki et al., 2013). The M90I variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M90I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret M90I as a disease-causing variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.